Cognition Conversations podcast

Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches

0:00
14:47
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Featuring:

Anthony Caggiano, M.D., Ph.D., Chief Medical Officer and Head of R&D, Cognition Therapeutics

Christopher H. van Dyck, M.D., Yale University School of Medicine, Professor of Psychiatry, Neurology, and Neuroscience

Director of the Division of Aging and Geriatric Psychiatry; Director of the Alzheimer’s Disease Research Center

Anton P. Porsteinsson, M.D., University of Rochester School of Medicine and Dentistry, William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine

Director of the Alzheimer’s Disease Care, Research and Education Program (AD-CARE)


Index:

0:00 Introduction

1:47 Reactions to lecanemab results

3:48 Impact of targeting plaque

6:46 Potentially complementary strategies

11:24 Future of Alzheimer’s therapies

13:40 Conclusion

Flere episoder fra "Cognition Conversations"